GLGuanghong Luo

Guanghong Luo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Guanghong Luo has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Top Cited Papers
    Open Access

    Noncancerous disease-targeting AIEgens

    by Yanhong Duo, Guanghong Luo, Wentao Zhang, Renzhi Wang, Gary Guishan Xiao, Zihuang Li, Xianming Li, Meili Chen, Juyoung Yoon, Ben Zhong Tang

    Schematic diagram of noncancerous disease-targeting AIEgens.


  • Niobium Diselenide Nanosheets: An Emerging Biodegradable Nanoplatform for Efficient Cancer Phototheranostics in the NIR‐II Window

    by Hanhan Xie, Shengyong Geng, Jundong Shao, Guanghong Luo, Qian Liu, Jiahong Wang, Yue Chen, Paul K. Chu, Zhibin Li, Xue‐Feng Yu

    As a prominent class of 2D transition metal dichalcogenides (TMDCs), niobium diselenide nanosheets (NbSe2 NSs) have garnered tremendous interest on account of promising applications pertaining to optoelectronics and energy storage. Although NbSe2 NSs have many unique advantages such as inherent biocompatibility and broad absorption in the NIR region, their biomedical applications have rarely been reported, especially as therapeutic agents for the second near‐infrared (NIR‐II) range. Herein, a biodegradable nanotherapeutic platform consisting of NbSe2 NSs is designed and demonstrated for NIR‐II light‐triggered photothermal therapy. NbSe2 NSs synthesized by grinding and liquid exfoliation exhibit superior photothermal conversion efficiency (48.3%) and remarkable photothermal stability in the NIR‐II region. In vitro assessment demonstrates that NbSe2 NSs have favorable photothermal cell ablation efficiency and biocompatibility. After intravenous injection in vivo, the NbSe2 NSs accumulate passively in tumor sites to facilitate fluorescence imaging and tumor ablation by NIR‐II illumination. Furthermore, as a result of gradual degradation in the physiological environment, NbSe2 NSs can be excreted from the body to avoid potential toxicity caused by long‐term retention in vivo. The results reveal a promising NIR‐II light‐triggered PTT strategy with the aid of NbSe2 NSs and the platform is expected to have large potential in cancer theranostics.


  • Open Access

    Molybdenum Diphosphide Nanorods with Laser‐Potentiated Peroxidase Catalytic/Mild‐Photothermal Therapy of Oral Cancer (Adv. Sci. 1/2022)

    by Min Qian, Ziqiang Cheng, Guanghong Luo, Massimiliano Galluzzi, Yuehong Shen, Zhibin Li, Hongyu Yang, Xue‐Feng Yu

  • Open Access

    Dcf1 induces glioblastoma cells apoptosis by blocking autophagy

    by Guanghong Luo, Ruili Feng, Wengang Li, Yanlu Chen, Yangyang Sun, Junfeng Ma, Yanhong Duo, Tieqiao Wen

    Background: Dcf1 has been demonstrated to play vital roles in many CNS diseases, it also has a destructive role on cell mitochondria in glioma cells and promotes the autophagy. Hitherto, it is unclear whether the viability of glioblastoma cells is affected by Dcf1, in particular Dcf1 possesses broad localization on different organelles, and the organelles interaction frequently implicated in cancer cells survival.Methods: Surgically excised WHO grade IV human glioblastoma tissues were collected and cells isolated for culturing. RT‐PCR and DNA sequencing assay to estimate the abundance and mutation of Dcf1. iTRAQ sequencing and bioinformatic analysis were performed. Subsequently, immunoprecipitation assay to evaluate the degradation of HistoneH2A isomers by UBA52 ubiquitylation. Transmission electron microscopy (TEM) was applied to observe the structure change of mitochondria and autophagosome. Organelle isolated assay to determine the distribution of protein. Cell cycle and apoptosis were evaluated by flow cytometric assays.Results: Dcf1 was downregulated in WHO grade IV tumor without mutation, and overexpression of Dcf1 was found to significantly regulate glioblastoma cells. One hundred and seventy‐six differentially expressed proteins were identified by iTRAQ sequencing. Furthermore, we confirmed that overexpression of Dcf1 destabilized the structure of the nucleosome via UBA52 ubiquitination to downregulate HistoneH2A.X but not macroH2A or HistoneH2A.Z, decreased the mitochondrial DNA copy number and inhibited the mitochondrial biogenesis, thus causing mitochondrial destruction and dysfunction in order to supply cellular energy and induce mitophagy preferentially but not apoptosis. Dcf1 also has disrupted the integrity of lysosomes to block autolysosome degradation and autophagy and to increase the release of Cathepsin B and D from lysosomes into cytosol. These proteins cleaved and activated BID to induce glioblastoma cells apoptosis.Conclusions: In this study, we demonstrated that unmutated Dcf1 expression is negatively related to the malignancy of glioblastoma, Dcf1 overexpression causes nucleosomes destabilization, mitochondria destruction and dysfunction to induce mitophagy preferentially, and block autophagy by impairing lysosomes to induce apoptosis in glioblastoma.


  • Complete ablation of resistant tumors with photosensitive black phosphorus quantum dots-based lipid nanocapsules

    by Shengyong Geng, Zhibin Li, Rui Zhang, Wenhua Zhou, Guanghong Luo, Paul K. Chu, Xue-Feng Yu


  • ARL3 subcellular localization and its suspected role in autophagy

    by Guanghong Luo, Yangyang Sun, Ruili Feng, Qinping Zhao, Tieqiao Wen